Abstract
This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Current Bioactive Compounds
Title:Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract
Volume: 12 Issue: 1
Author(s): Fatah Keffous, Nasser Belboukhari, Houria Djaradi, Abdelkrim Cheriti, Khaled Sekkoum and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Abstract: This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Export Options
About this article
Cite this article as:
Keffous Fatah, Belboukhari Nasser, Djaradi Houria, Cheriti Abdelkrim, Sekkoum Khaled and Y. Aboul-Enein Hassan, Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666160210230707
DOI https://dx.doi.org/10.2174/1573407212666160210230707 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alternative Approach for Mitigation of Doxorubicin-Induced Cardiotoxicity using Herbal Agents
Current Clinical Pharmacology Clinical Presentations and Diagnosis of Brucellosis
Recent Patents on Anti-Infective Drug Discovery Management of COVID-19 very Elderly Patients in Nursing Homes and Long-Term Care Facilities: Description of a New Model and Experience in a Medicalized Nursing Home
Coronaviruses An Overview of Compounds Derived from the Shikimate and Phenylpropanoid Pathways and Their Medicinal Importance
Mini-Reviews in Medicinal Chemistry Measurement of Physical Changes in the Myocardium for Development of Novel Methods for Diagnosing Ischemia
Current Cardiology Reviews Bioactive Compounds in Diabetic Cardiomyopathy: Current Approaches and Potential Diagnostic and Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis
Current Pharmaceutical Design Structure of Atherosclerotic Plaques in Different Vascular Territories: Clinical Relevance
Current Vascular Pharmacology Can Exercise Minimize Postprandial Oxidative Stress in Patients with Type 2 Diabetes?
Current Diabetes Reviews The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
Current Pharmaceutical Design Olive Oil and Haemostasis
Current Nutrition & Food Science How Much Gets there and What Does it Do?: The Need for Better Pharmacokinetic and Pharmacodynamic Endpoints in Contemporary Drug Discovery and Development
Current Pharmaceutical Design High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Aging and Oral Health: Effects in Hard and Soft Tissues
Current Pharmaceutical Design Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology The Role of COX-2 in Heart Pathology
Cardiovascular & Hematological Agents in Medicinal Chemistry The Potential Impact of Sirtuin 1 Protein on Premature Ovarian Insufficiency
Current Proteomics Development of Standardized <i>Cyanthillium cinereum</i> (L.) H.Rob. Extract and Determination of its Biological Activities
The Natural Products Journal The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Dyslipidemia as a Risk Factor for Ischemic Stroke
Current Topics in Medicinal Chemistry